Nano Retina
Nano Retina is an Israel-based medical device company developing the NR600 artificial retina implant and wireless eyeglasses system to restore vision in patients with retinal degenerative diseases such as retinitis pigmentosa and macular degeneration.
- Company typePrivate
- Founded2009
- HeadquartersHerzliya, Israel
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Nano Retina does
Nano Retina, Inc. is an Israeli medical device company developing the NR600 artificial retina system intended to restore vision in patients with retinal degenerative diseases such as retinitis pigmentosa and age-related macular degeneration. The product consists of two components: the NR600 Implant, an ultra-small artificial retina featuring proprietary 3DNi™ (3-Dimensional Nano Interface) technology with 3D penetrating shape electrodes, sophisticated nano-coating, and high-density electrodes; and the NR600 Eyeglasses, a wireless external unit that powers the implant and captures/transmits visual information to it. The technology is grounded in 35 years of underlying scientific research and a cross-disciplinary team of physicists, engineers, ophthalmologists, retinal surgeons, and low-vision specialists.
The company's revenue model is hardware sales of the NR600 system to healthcare providers and patients, distributed through eye hospitals, retinal surgery centers, and qualified ophthalmologists, with the implant requiring surgical placement by trained retinal surgeons. Pricing is not publicly disclosed; the company operates as a privately held subsidiary of the Rainbow Medical Group, an Israeli medical device conglomerate. As of the available data, the company remains pre-commercial, conducting clinical studies with no disclosed funding rounds or revenue. Patient-facing materials have been published in English, Italian, Dutch, Russian, Arabic, and Hebrew, suggesting planned international reach beyond Israel as commercialization progresses.
Nano Retina firmographics
Firmographics- Name
- Nano Retina
- Legal name
- Nano Retina
- Website
- https://nano-retina.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Nano Retina is an Israel-based medical device company developing the NR600 artificial retina implant and wireless eyeglasses system to restore vision in patients with retinal degenerative diseases such as retinitis pigmentosa and macular degeneration.
- Ownership category
- akta.pro rank
Nano Retina industry classification
Industry- Product category
- Retinal Prosthesis / Artificial Retina Medical Device
- NAICS
- Ophthalmic Goods Manufacturing (339115), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Ophthalmic Goods (3851), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Low Vision & Assistive Vision Devices (Magnifiers, Electronic Video Magnifiers, Wearable Vision Aids) (HLAHAJAN)
Keywords
Where Nano Retina is headquartered
LocationHeadquarters
- HQ city
- Herzliya
- HQ country
- Israel
- HQ region
- Middle East
Offices1 record
Markets served
Nano Retina business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Artificial Retina Implant System: Revenue generated from the sale of the NR600 Implant and NR600 Eyeglasses system to healthcare providers and patients with retinal degenerative diseases.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Nano Retina product offering
Product offeringCore offering
Nano Retina is developing an ultra-small, easy-to-implant artificial retina system designed to restore sight to patients with retinal degenerative diseases. The product consists of two components: the NR600 Implant, an artificial retina device using proprietary 3DNi (3-Dimensional Nano Interface) technology with 3D penetrating shape electrodes and high density electrodes, and the NR600 Eyeglasses, a wireless external unit that powers the implant and captures/transmits visual information. The system is intended to provide higher resolution image quality at a lower risk profile compared to alternative retinal prostheses.
Product overview
Nano Retina offers a two-component artificial retina system consisting of the NR600 Implant and NR600 Eyeglasses. The implant is an artificial retina device that replaces the natural function of the diseased retina, utilizing proprietary 3DNi technology with 3D penetrating shape electrodes, sophisticated nano technology coating, and high density electrodes. The wireless NR600 Eyeglasses work in conjunction with the implant. The system is designed to provide higher resolution image quality at a lower risk profile compared to alternative retinal prostheses.
Differentiator
Problem solved
Functional benefit
Brands
- NR600: The NR600 system consists of an implant and wireless eyeglasses designed to restore vision for patients with retinal degenerative diseases
- 3DNi™
Products and services
- NR600 Implant
- NR600 Eyeglasses Wireless eyeglasses that constitute the second component of the Nano Retina system, designed to power the NR600 Implant and capture and transmit visual information to the artificial retina. Works in conjunction with the implant and is part of the two-component artificial retina solution.
Companies that use Nano Retina
Customer profileSegments1 record
Ideal customer profiles2 records
Nano Retina technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Nano Retina partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Rainbow Medical GroupcoreNano Retina is a member of the Rainbow Medical Group, an Israeli medical device group focused on innovative medical technologies. Rainbow Medical Group provides corporate backing and potentially shared resources for Nano Retina's artificial retina development.
Scale indicators2 records
Recent moves5 records
Expansion highlights4 records
Nano Retina competitors and assessment
Company assessmentBroad incumbents
- Cochlear Limited: Global leader in implantable neural prosthetics (cochlear implants) with established regulatory, manufacturing, and surgical-channel infrastructure relevant to any implantable sensory-neural prosthesis including artificial-retina technologies like Nano Retina's NR600.
- Abbott Neuromodulation: Owns the Proclaim DRG and spinal-cord-stim platforms inherited from St. Jude Medical, giving it scale in implantable neurostimulators directly comparable to the device-class of Nano Retina's retinal prosthesis.
- Medtronic Neuromodulation: Diversified medtech with a leading neuromodulation portfolio (DBS, spinal cord stim, targeted drug delivery). Adjacent implantable neurostimulation capability makes it both a strategic comparator and a potential strategic-acquirer profile for Nano Retina.
- Boston Scientific Neuromodulation: A major neuromodulation franchise (spinal cord stimulators, DBS) with deep expertise in implantable electrode-based neurostimulators that competes for talent, partners, and acquirers in the implantable neural-prosthetic category in which Nano Retina operates.
Emerging players
- Bionic Vision Technologies: Australian research-stage developer of a suprachoroidal retinal prosthesis (the BVT system) and successor efforts aimed at restoring vision in retinal degenerative patients. Comparable artificial-retina effort at an earlier clinical maturity stage than Nano Retina.
Direct peers
- Pixium Vision: French medtech developing the PRIMA wireless sub-retinal photovoltaic prosthesis for age-related macular degeneration. Directly competes head-to-head with Nano Retina in the sub-retinal/prosthetic artificial-retina space targeting retinal degenerative disease patients.
- Retina Implant AG: German developer of the Alpha IMS sub-retinal prosthesis implant for retinitis pigmentosa. Closely comparable sub-retinal stimulation approach and indication, representing a direct peer in the artificial-retina category.
- Vivani Medical (formerly Second Sight Medical Products): Developer of the Argus II retinal prosthesis, the first FDA-approved artificial retina. Direct competitor in restoring vision via an implantable retinal stimulation device for retinitis pigmentosa and similar degenerations, addressing the same patient population as Nano Retina's NR600.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Nano Retina social profiles
Digital presenceNano Retina financial estimates
Financial estimateRevenue estimate
Valuation estimate
Nano Retina leadership team
Management profileNumber of profiles
Profiles3 records
Nano Retina funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Nano Retina M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Nano Retina
What does Nano Retina do?
Nano Retina is developing an ultra-small, easy-to-implant artificial retina system designed to restore sight to patients with retinal degenerative diseases. The product consists of two components: the NR600 Implant, an artificial retina device using proprietary 3DNi (3-Dimensional Nano Interface) technology with 3D penetrating shape electrodes and high density electrodes, and the NR600 Eyeglasses, a wireless external unit that powers the implant and captures/transmits visual information. The system is intended to provide higher resolution image quality at a lower risk profile compared to alternative retinal prostheses.
Is Nano Retina a public or private company?
Nano Retina is a private company. It is classified as corporate owned and is currently operating.
When was Nano Retina founded?
Nano Retina was founded in 2009. It employs 1 to 10 people.
Where is Nano Retina based?
Nano Retina is headquartered in Herzliya, Israel, in the Middle East region.
How does Nano Retina make money?
One revenue line is on record: artificial Retina Implant System.
Who are Nano Retina's main competitors?
Broad incumbents on record are Cochlear Limited, Abbott Neuromodulation, Medtronic Neuromodulation and Boston Scientific Neuromodulation. Bionic Vision Technologies is listed as an emerging player. Direct peers are Pixium Vision, Retina Implant AG and Vivani Medical (formerly Second Sight Medical Products).
Does Nano Retina have an API?
No public API is recorded for Nano Retina.
What industry is Nano Retina in?
Nano Retina's product category is Retinal Prosthesis / Artificial Retina Medical Device. Its primary akta.pro industry code is HLAHAJAN, Low Vision & Assistive Vision Devices (Magnifiers, Electronic Video Magnifiers, Wearable Vision Aids). Its NAICS code is 339115 and its SIC code is 3851.